Web12 de abr. de 2024 · Dyslipidemia treatment is of major importance in reducing the risk of atherosclerotic cardiovascular disease (ASCVD), which is still the most common cause of death worldwide. During the last decade, a novel lipid-lowering drug category has emerged, i.e., proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. Apart from the two … Web12 de abr. de 2024 · Primary endpoint rates did not differ between the combo group (moderate-intensity statin plus ezetimibe) or the monotherapy group (high-intensity statin monotherapy group). For patients aged ≥75 years, the primary outcome rates were 10.6% for the combination group and 12.3% for the monotherapy group (hazard ratio [HR], 0.87; …
Table 5. Statin Dose Intensity and Equivalency Chart* - MQIC
Web1 de mai. de 2024 · 1.2.5 Ensure that people with stable neurological symptoms from acute non-disabling stroke or TIA who have symptomatic carotid stenosis of less than 50% according to the NASCET criteria, or less than 70% according to the European Carotid Surgery Trial (ECST) criteria: do not have surgery Web2. Statin therapy has shown clear benefits and is recommended in four major groups of patients (strong evidence): 1,2. Patient Group Recommended Intensity of Statin Treatment Clinical ASCVD* Age ≤ 75 years with no statin-related safety concerns † a High Age > 75 years or with statin-related safety concerns Moderate . LDL . ≥ 190 mg/dL ... how to stop arousal biting in dogs
High-Intensity Statins Benefit High-Risk Patients: Why and …
Web19 de jan. de 2024 · Currently, experts recommend high intensity statins for four groups of people: 1) Those who have athersclerotic cardiovascular disease ( ASCVD) and are … WebHigh intensity statin treatment is the most clinically effective option for the prevention of CVD. However, statins at any intensity reduce CVD risk compared with no treatment. The adverse effects of statins are generally mild, reversible, and not medically serious, although some people may find them distressing. WebFor example, both the UK and European guidelines recommend that ezetimibe is used alongside statin therapy in patients at high risk of CVD if lipid lowering goals are not achieved with the maximum tolerated dose of statin, or in cases where statin cannot be prescribed. 6,13,14 Yet, despite the known benefits of adding ezetimibe, particularly for … how to stop arrow keys from highlighting text